[go: up one dir, main page]

NO20081481L - Farmasoytisk sammensetning inneholdende carvedilol, med regulert frigivning - Google Patents

Farmasoytisk sammensetning inneholdende carvedilol, med regulert frigivning

Info

Publication number
NO20081481L
NO20081481L NO20081481A NO20081481A NO20081481L NO 20081481 L NO20081481 L NO 20081481L NO 20081481 A NO20081481 A NO 20081481A NO 20081481 A NO20081481 A NO 20081481A NO 20081481 L NO20081481 L NO 20081481L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
controlled release
composition containing
containing carvedilol
carvedilol
Prior art date
Application number
NO20081481A
Other languages
English (en)
Inventor
Pal Fekete
Zoltan Budavari
Agnes Bozso
Magdolna Leventiszne Huszar
Zoltanne Palfi
Palne Szentgroti
Erika Davidne Karacs
Aniko Turoczine Kuncze
Krisztina Abraham
Zsolt Zsigmond
Original Assignee
Egis Gyogyszergyar Nyilvanosan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Nyilvanosan filed Critical Egis Gyogyszergyar Nyilvanosan
Publication of NO20081481L publication Critical patent/NO20081481L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Foreliggende oppfinnelse relaterer til en kontrollert frigivning farmasøytisk sammensetning i en sjikt pellet form inneholdende karvedilol. Sammensetningen inneholder en kjerne inneholdende en fast organisk syre, et enterisk beleggsjikt på kjernen, et sjikt inneholdende karvedilol og et vannoppløselig adhesiv på overflaten av det enteriske belegg, og et oppløsningskontrollerende sjikt inneholdende en blanding av vannoppløselige og enteriske polymerer.
NO20081481A 2005-08-26 2008-03-26 Farmasoytisk sammensetning inneholdende carvedilol, med regulert frigivning NO20081481L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0500803A HU227490B1 (en) 2005-08-26 2005-08-26 Sustained release pharmaceutical preparation containing carvedilol
PCT/HU2006/000068 WO2007023325A2 (en) 2005-08-26 2006-08-23 Controlled release pharmaceutical composition containing carvedilol

Publications (1)

Publication Number Publication Date
NO20081481L true NO20081481L (no) 2008-05-19

Family

ID=89986232

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081481A NO20081481L (no) 2005-08-26 2008-03-26 Farmasoytisk sammensetning inneholdende carvedilol, med regulert frigivning

Country Status (11)

Country Link
EP (1) EP1928431B8 (no)
AT (1) ATE418969T1 (no)
DE (1) DE602006004610D1 (no)
DK (1) DK1928431T3 (no)
EA (1) EA013058B1 (no)
ES (1) ES2321980T3 (no)
HU (1) HU227490B1 (no)
NO (1) NO20081481L (no)
PL (1) PL1928431T3 (no)
PT (1) PT1928431E (no)
WO (1) WO2007023325A2 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
EP1912650B8 (en) 2005-08-03 2017-10-18 Sprout Pharmaceuticals, Inc. Use of flibanserin in the treatment of obesity
EP1945214A1 (en) 2005-10-29 2008-07-23 Boehringer Ingelheim International GmbH Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
KR20140088230A (ko) * 2006-01-27 2014-07-09 앱탈리스 파마테크, 인코포레이티드 약 염기성 약물과 유기산을 포함하는 약물 전달 시스템
JP2009541443A (ja) 2006-06-30 2009-11-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 尿失禁及び関連疾患の治療のためのフリバンセリン
KR20090042967A (ko) 2006-08-14 2009-05-04 베링거 인겔하임 인터내셔날 게엠베하 플리반세린 제형 및 이의 제조방법
CN104721168A (zh) * 2006-08-25 2015-06-24 贝林格尔·英格海姆国际有限公司 控制释放系统及其制造方法
HU227881B1 (en) * 2007-02-23 2012-05-29 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Sustained release pharmaceutical preparation containing carvedilol
CL2008002693A1 (es) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
JP5204847B2 (ja) 2007-09-21 2013-06-05 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング エタノールの影響に対して耐性を有するｐｈ依存性制御放出医薬オピオイド組成物
WO2009047800A2 (en) * 2007-10-09 2009-04-16 Lupin Limited Oral controlled release composition of carvedilol
US8133506B2 (en) * 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
CN103099793B (zh) * 2013-02-06 2015-07-15 中国人民解放军第二军医大学 片剂及其制备方法
JP7336187B2 (ja) * 2017-11-30 2023-08-31 日本ケミファ株式会社 多層構造を有する粒子状医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2426811A1 (en) * 2000-10-24 2002-08-29 Smithkline Beecham Corporation Novel formulations of carvedilol
DE10209982A1 (de) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe
AU2003288608A1 (en) * 2002-12-20 2004-07-14 Ranbaxy Laboratories Limited Controlled release, multiple unit drug delivery systems

Also Published As

Publication number Publication date
HU227490B1 (en) 2011-07-28
WO2007023325A3 (en) 2007-06-28
ATE418969T1 (de) 2009-01-15
EA013058B1 (ru) 2010-02-26
EP1928431A2 (en) 2008-06-11
HU0500803D0 (en) 2005-11-28
PT1928431E (pt) 2009-03-25
EP1928431B1 (en) 2008-12-31
EA200800666A1 (ru) 2008-06-30
HUP0500803A2 (en) 2007-05-29
EP1928431B8 (en) 2009-04-08
DE602006004610D1 (de) 2009-02-12
WO2007023325A2 (en) 2007-03-01
ES2321980T3 (es) 2009-06-15
HUP0500803A3 (en) 2008-03-28
PL1928431T3 (pl) 2009-07-31
DK1928431T3 (da) 2009-04-20

Similar Documents

Publication Publication Date Title
NO20081481L (no) Farmasoytisk sammensetning inneholdende carvedilol, med regulert frigivning
WO2011063089A3 (en) Surface-modified adhesives
WO2009009628A3 (en) Endoprosthesis coating
WO2008132045A3 (en) Substrates with biocidal coating
MX2012008908A (es) Pelicula que se puede rotular con laser resistente al calor.
WO2010017558A3 (en) Composite material compositions and methods
BR112012013076A2 (pt) processo para revestir substratos cerâmicos, e, substrato cerâmico.
WO2011060256A3 (en) Bilayer tablet formulations
ATE538185T1 (de) Laserempfindliche beschichtungszusammensetzung
TWI370160B (en) Conductive polymer coating composition, method of preparing coating film using the conductive polymer coating composition, and coating film prepared using the method
WO2012163678A3 (de) Verfahren zur herstellung geschäumter tapeten
DK2054502T3 (da) Nykonstrueret mikroorganisme, der producerer homo-ravsyre, og fremgangsmåde til fremstilling af ravsyre ved anvendelse af samme
WO2010112358A3 (de) Verfahren zur beschichtung einer oberfläche eines bauteils
WO2010029331A3 (en) Colour forming composition
MX2010010053A (es) Granulos.
MX2012000656A (es) Materiales de componentes multiples que tienen una composicion que cambia de color.
WO2010022132A3 (en) Biocompatible coatings, and methods of making and using the same
CL2008002551A1 (es) Aducto amina-funcional; composicion curable, multicomponentes ; sustrato recubierto con dicha composicion; y procedimiento para proveer un recubrimiento a un sustrato
WO2017123381A3 (en) Antifog coating composition and method of making thereof
WO2008123233A1 (ja) 感放射線樹脂組成物、アクティブマトリックス基板及びその製造方法
JP2009007185A5 (no)
WO2005077365A3 (en) Novel uses for proton pump inhibitors
WO2009138608A3 (fr) Composition stable destinee a l'assemblage demontable de substrats par collage
NZ545546A (en) Method for preparing a coated substrate
WO2008092649A3 (de) Farbige markierung und beschriftung mittels energiereicher strahlung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application